This Practice Alert highlights some recent practice issues reported to PDL Professional Officers. Respiratory Syncytial Virus (RSV) vaccines Currently, two Respiratory Syncytial Virus (RSV) vaccines, Arexvy® and Abrysvo®, have been approved by the Therapeutic Goods Administration (TGA) for prote…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article
Have you received an Ahpra notification?
15 October 2024
NationalProfessional activitiesPharmacist prescribing
Learn more